Days after approving a $150 million class action settlement between direct purchasers of nasal spray Flonase and manufacturer GlaxoSmithKline, a federal judge has approved a $35 million settlement between GSK and the indirect purchasers of the drug.
This article requires free registration to Law.com. Please sign in or register to read the full text.
No comments:
Post a Comment